×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
ON DEMAND - PMDA Town Hall: The Path of a New Chief Executive Since His Appointment
Session Chair(s)
Nobumasa Nakashima
Health Policy Director, National Healthcare Policy Secretariat
Cabinet Office, Japan
Last year, Dr. Yasuhiro Fujiwara, a new chief executive, has announced a new policy “4Fs”. PMDA is working effectively toward the realization of his goal. In this session, PMDA will share the latest details regarding its policies and initiatives.
Learning Objective : Discuss the latest information regarding PMDA and Japanese regulations; Explain how to foster dialogue between participants and senior PMDA officials concerning drug/device regulatory concerns.
Speaker(s)
Panelist
Yasuhiro Fujiwara, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Panelist
Hiroyuki Arai, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Executive Director
Panelist
Naoyuki Yasuda, MSc
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director , Office of International Programs
Have an account?